Gossamer Bio (GOSS) Change in Account Payables (2018 - 2026)

Gossamer Bio's Change in Account Payables history runs 9 years deep, the most recent figure standing at $6.2 million for Q1 2026.

• In Q1 2026, Change in Account Payables rose 756.99% year-over-year to $6.2 million; the TTM figure through Mar 2026 stood at $4.3 million (up 1212.99% YoY), while the FY2025 annual figure was -$2.7 million, down 65.88% from the prior year.
• Change in Account Payables for Q1 2026 stood at $6.2 million, up from $4.8 million in the prior quarter.
• The five-year high for Change in Account Payables was $6.2 million in Q1 2026, with the low at -$5.8 million in Q2 2025.
• The 5-year median for Change in Account Payables is -$507000.0 (2023), against an average of $231176.5.
• Peak annual rise in Change in Account Payables reached 5722.73% in 2022, while the deepest fall reached 1765.54% in 2022.
• Gossamer Bio's Change in Account Payables stood at $285000.0 in 2022, then surged by 1395.44% to $4.3 million in 2023, then slipped by 27.73% to $3.1 million in 2024, then surged by 56.56% to $4.8 million in 2025, then climbed by 27.66% to $6.2 million in 2026.
• Business Quant data shows GOSS's Change in Account Payables at $6.2 million in Q1 2026, $4.8 million in Q4 2025, and -$795000.0 in Q3 2025.